MCID: SKN027
MIFTS: 51

Skin Conditions

Categories: Immune diseases, Skin diseases

Aliases & Classifications for Skin Conditions

MalaCards integrated aliases for Skin Conditions:

Name: Skin Conditions 39 44
Dermatologic Disorders 74

Classifications:



External Ids:

UMLS 74 C0037274

Summaries for Skin Conditions

MedlinePlus : 44 Your skin is your body's largest organ. It covers and protects your body. Your skin Holds body fluids in, preventing dehydration Keeps harmful microbes out, preventing infections Helps you feel things like heat, cold, and pain Keeps your body temperature even Makes vitamin D when the sun shines on it Anything that irritates, clogs, or inflames your skin can cause symptoms such as redness, swelling, burning, and itching. Allergies, irritants, your genetic makeup, and certain diseases and immune system problems can cause rashes, hives, and other skin conditions. Many skin problems, such as acne, also affect your appearance. NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases

MalaCards based summary : Skin Conditions, also known as dermatologic disorders, is related to contact dermatitis and dermatitis, and has symptoms including pruritus, dry skin and enanthema. An important gene associated with Skin Conditions is AIM2 (Absent In Melanoma 2), and among its related pathways/superpathways are Toll-like Receptor Signaling Pathway and Th17 cell differentiation. The drugs Dapsone and leucovorin have been mentioned in the context of this disorder. Affiliated tissues include skin, breast and testes.

Related Diseases for Skin Conditions

Diseases related to Skin Conditions via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 144)
# Related Disease Score Top Affiliating Genes
1 contact dermatitis 29.8 IL1A TNF
2 dermatitis 11.0
3 seborrheic dermatitis 10.9
4 lymphomatoid papulosis 10.9
5 discoid lupus erythematosus 10.9
6 darier-white disease 10.7
7 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 10.7
8 erythroderma, ichthyosiform, congenital reticular 10.7
9 crouzon syndrome with acanthosis nigricans 10.7
10 nevoid hypermelanosis, linear and whorled 10.7
11 dowling-degos disease 10.7
12 granulomatous rosacea 10.7
13 scleredema 10.7
14 transient bullous dermolysis of the newborn 10.6
15 erythrokeratodermia variabilis et progressiva 1 10.6
16 melanocytic nevus syndrome, congenital 10.6
17 lenz-majewski hyperostotic dwarfism 10.6
18 nail disorder, nonsyndromic congenital, 1 10.6
19 benign chronic pemphigus 10.6
20 pityriasis rubra pilaris 10.6
21 porokeratosis 1, multiple types 10.6
22 rothmund-thomson syndrome 10.6
23 restrictive dermopathy, lethal 10.6
24 wiskott-aldrich syndrome 10.6
25 ichthyosis, x-linked 10.6
26 vitiligo-associated multiple autoimmune disease susceptibility 1 10.6
27 neutrophilic dermatosis, acute febrile 10.6
28 psoriasis 14, pustular 10.6
29 achondroplasia, severe, with developmental delay and acanthosis nigricans 10.6
30 granuloma annulare 10.6
31 erythema multiforme 10.6
32 acquired generalized lipodystrophy 10.6
33 junctional epidermolysis bullosa 10.6
34 palmoplantar keratosis 10.6
35 necrobiosis lipoidica 10.6
36 porokeratosis 10.6
37 photoallergic dermatitis 10.6
38 achenbach syndrome 10.6
39 inverted follicular keratosis 10.6
40 scabies 10.6
41 dermatitis herpetiformis 10.6
42 rosacea 10.6
43 pityriasis versicolor 10.6
44 aquagenic pruritus 10.6
45 erythema nodosum, idiopathic 10.6
46 gianotti crosti syndrome 10.6
47 glucagonoma 10.6
48 grover's disease 10.6
49 guttate psoriasis 10.6
50 hydroa vacciniforme 10.6

Graphical network of the top 20 diseases related to Skin Conditions:



Diseases related to Skin Conditions

Symptoms & Phenotypes for Skin Conditions

UMLS symptoms related to Skin Conditions:


pruritus, dry skin, enanthema, exanthema, skin manifestations, nasal itching

Drugs & Therapeutics for Skin Conditions

Drugs for Skin Conditions (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1454)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dapsone Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 80-08-0 2955
2
leucovorin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 58-05-9 143 6006
3
mometasone furoate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83919-23-7
4
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 104987-11-3 6473866 445643 439492
5
Metformin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 657-24-9 14219 4091
6
Acitretin Approved Phase 4,Phase 3,Phase 2,Not Applicable 55079-83-9, 69427-46-9 6437841
7
tannic acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 1401-55-4
8
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 1994-09-7, 94-09-7 2337
9
Acetylcholine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-84-3 187
10
Ethanol Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 64-17-5 702
11
Petrolatum Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 8009-03-8
12
Titanium dioxide Approved Phase 4,Phase 2,Not Applicable 13463-67-7
13
Adalimumab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 331731-18-1 16219006
14
Etanercept Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 185243-69-0
15
Infliximab Approved Phase 4,Phase 3,Phase 2,Not Applicable 170277-31-3
16
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 1959-05-2, 59-05-2 126941
17
Certolizumab pegol Approved Phase 4,Phase 3,Phase 2 428863-50-7
18
Ustekinumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 815610-63-0
19
Desonide Approved, Investigational Phase 4,Phase 3,Not Applicable 638-94-8 5311066
20
Esomeprazole Approved, Investigational Phase 4,Phase 1 161796-78-7, 161973-10-0, 119141-88-7 9568614 4594
21
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 22916-47-8 4189
22
Ciclopirox Approved, Investigational Phase 4,Phase 3 29342-05-0 2749
23
Amorolfine Approved, Investigational Phase 4,Phase 3 78613-35-1
24
Coal tar Approved Phase 4,Phase 3,Phase 1,Not Applicable 8007-45-2
25
Fluorouracil Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 51-21-8 3385
26
Chlorhexidine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 55-56-1 2713 9552079
27
Phenol Approved, Experimental Phase 4,Not Applicable 108-95-2 996
28
Clindamycin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 18323-44-9 29029
29
carbamide peroxide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 124-43-6
30
Clobetasol Approved, Experimental, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 25122-46-7, 25122-41-2 5311051 32798
31
Mineral oil Approved, Vet_approved Phase 4,Phase 1,Phase 2,Not Applicable 8042-47-5
32
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 124-94-7 31307
33
Glycerol Approved, Investigational Phase 4,Phase 2,Phase 1,Not Applicable 56-81-5 753
34
Aminolevulinic acid Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 106-60-5 137
35
Isotretinoin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 4759-48-2 5282379 5538
36
Salicylic acid Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 69-72-7 338
37
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 51-45-6 774
38
Fexofenadine Approved, Investigational Phase 4,Phase 2 83799-24-0 3348
39
Gabapentin Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 60142-96-3 3446
40
Pregabalin Approved, Illicit, Investigational Phase 4,Not Applicable 148553-50-8 5486971
41
Imiquimod Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 99011-02-6 57469
42
Benzoyl peroxide Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 94-36-0 7187
43
acetic acid Approved Phase 4 64-19-7 176
44
Hydroquinone Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 123-31-9 785
45
Menthol Approved Phase 4,Phase 3 2216-51-5 16666
46
Zinc Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 7440-66-6 32051
47
Zinc oxide Approved Phase 4,Phase 3,Phase 2,Not Applicable 1314-13-2
48
Fluticasone Approved, Experimental Phase 4,Early Phase 1,Not Applicable 90566-53-3 62924
49
Pimecrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 137071-32-0 17753757 6447131
50
Azelaic acid Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 123-99-9 2266

Interventional clinical trials:

(show top 50) (show all 10005)
# Name Status NCT ID Phase Drugs
1 The Effect of Anti-bacterial Honey Dressing on the Healing of Split Thickness Skin Graft Donor Site Unknown status NCT02400372 Phase 4
2 Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome Unknown status NCT02550080 Phase 4 Dapsone
3 Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo Unknown status NCT01333410 Phase 4 tacrolimus ointment;Mometasone furoate
4 Study of Efficacy of Metformin in the Treatment of Acanthosis Nigricans in Children With Obesity Unknown status NCT02438020 Phase 4 Metformin
5 Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects? Unknown status NCT01228409 Phase 4 Acitretin 17.5 mg/day
6 Weight Reduction Alone May Not be Sufficient to Maintain Disease Remission in Obese Patients With Psoriasis Unknown status NCT01439425 Phase 4
7 The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction Unknown status NCT01427400 Phase 4 Botulinum Toxin-A;Saline
8 Mometasone Furoate Cream Reduces Acute Radiation Dermatitis in Head and Neck Squamous Cell Carcinomas' Patients Unknown status NCT02495064 Phase 4 Mometasone Furoate Cream
9 RHYTHM (Formerly Escape II Myocardium) Unknown status NCT01548768 Phase 4 TNF inhibitors;DMARDs
10 The Difference of Microparticles in Patients With Psoriasis Vulgaris Who Received Stelara(Ustekinumab) Unknown status NCT02693470 Phase 4 Ustekinumab
11 Proton Pump Inhibitors Use in Patients With Psoriasis Unknown status NCT02624544 Phase 4 esomeprazole;desonide
12 Quality of Life of Patients With Psoriasis Treated With Methotrexate: Prospective, Randomized, Double-blind, Parallel Group Study. Unknown status NCT02248792 Phase 4 Methotrexate
13 Intense Pulsed Light as an Adjunctive to Bromonidine for the Treatment of Rosacea Unknown status NCT03053700 Phase 4 Bromonide 0.33% gel
14 A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis Unknown status NCT01558310 Phase 4 Ustekinumab;Placebo
15 Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2 Unknown status NCT01443338 Phase 4 Triptergium Wilfordii;Acitretin
16 Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors Therapy Unknown status NCT01237262 Phase 4 Adalimumab, etanercept, infliximab
17 An Open-label Study to Evaluate the Efficacy of Re-treatment for Patients With a History of Etanercept Use Unknown status NCT01132235 Phase 4
18 Combining Acitretin and Efalizumab in the Therapy of Chronic Plaque Psoriasis Unknown status NCT00707070 Phase 4 efalizumab plus placebo;efalizumab plus acitretin
19 Home UVB Phototherapy for Psoriasis: Effectiveness, Quality of Life and Cost-Effectiveness Unknown status NCT00150930 Phase 4
20 Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic Onychomycosis Unknown status NCT01014637 Phase 4 Amorolfine (Antifungal);RV4104A, Ciclopiroxolamine, Cyclopirox (Keratolytic Agents/Antifungal)
21 Study on the Effects of Oxygen-ozone Therapy on Back Pain in Subjects Aged 65 or Older Unknown status NCT01709058 Phase 4 Intramuscular/paravertebral injections of Oxygen-Ozone
22 Conventional Microneedling vs Microneedling With 5-FU (MMP) for Idiopathic Guttate Hypomelanosis (IGH) Repigmentation Unknown status NCT02904564 Phase 4
23 Effectiveness of Lavage With Alcohol - Chlorhexidine for Chemical Matricectomy Unknown status NCT01844141 Phase 4 70% alcohol;70% alcohol - 0.5% clorhexidine
24 Efficacy & Safety of Clindamycin and Tretinoin in Acne Unknown status NCT01111994 Phase 4 Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel
25 Efficacy and Safety of Runzao Zhiyang Capsule to Treat Chronic Eczema Unknown status NCT02601222 Phase 4 Runzao zhiyang capsule;Runzaozhiyang capsule agent simulation;Urea cream
26 Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation Unknown status NCT00779792 Phase 4 clobetasol;triamcinolone acetonide;tacrolimus;glycerol;vehicle ointment (paraffin oil/soft white paraffin)
27 Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate Unknown status NCT01491711 Phase 4 Methylaminolevulinate PDT in 2 sessions;Fractionated 5-aminolevulinic acid hydrochloride 20% gel PDT
28 Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea Unknown status NCT01139749 Phase 4 oral isotretinoin;salicylic acid and ciclopirox olamine
29 Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA Gel Unknown status NCT02647151 Phase 4 METHYLAMINOLEVULINATE HYDROCHLORIDE;AMINOLEVULINIC ACID HYDROCHLORIDE
30 Pregabalin for the Treatment of Uremic Pruritus Unknown status NCT01852318 Phase 4 pregabalin 75mg daily for 12 weeks;fexofenadine 60 mg daily for 12 weeks;placebo
31 Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis Unknown status NCT01656226 Phase 4
32 Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis Unknown status NCT01413763 Phase 4 Imiquimod cream 3.75%;Placebo cream
33 Efficacy of Pregabalin in the Management of Chronic Uremic Pruritus Unknown status NCT01073501 Phase 4 Pregabalin;Placebo
34 Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris Unknown status NCT01448733 Phase 4 Benzoyl peroxide 2.5%/clindamycin phosphate 1.2% in the morning with with tretinoin 0.05% gel in the evening
35 A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne Unknown status NCT01422785 Phase 4 clindamycin phosphate 1.2%/tretinoin 0.025% gel alone;clindamycin phosphate 1.2%/tretinoin 0.025% gel plus benzoyl peroxide 6% foaming cloths
36 Clinical Study to Evaluate the Efficacy of Topical Medications Containing Benzoyl Peroxide and Sulfur in the Regression in the Short Time (24 Hours) of Moderate Acne Vulgaris Grade II (Pimples) Unknown status NCT01260571 Phase 4 Benzoyl peroxide and sulfur
37 Efficacy of Quantum NPWT With Simultaneous Irrigation on Reduction of Wound Volume in Stage III/IV Pressure Ulcers. Unknown status NCT01734109 Phase 4
38 Clinical Trial of Hydroquinone Versus Miconazol in Melasma Unknown status NCT01661556 Phase 4 Miconazole;Hydroquinone
39 Olive Oil's Cream Effectiveness in Prevention of Pressure Ulcers in Immobilized Patients in Primary Care Unknown status NCT01595347 Phase 4 Hyper-oxigenated fatty acid
40 Trial Comparing Calmoseptine Ointment and Desitin Diaper Rash Paste in Diaper Dermatitis in Neonates and Infants Unknown status NCT02716415 Phase 4 Calmoseptine Ointment;Destin Maximum Strength 40% Zinc
41 Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo Unknown status NCT01246921 Phase 4 Fluticasone proprionate 0.05% cream
42 Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis) Unknown status NCT01082393 Phase 4 topical tacrolimus treatment;topical pimecrolimus treatment;local mometasone furoate treatment;cold cream
43 Azelaic Acid Versus Hydroquinone in Melasma Unknown status NCT00927771 Phase 4 azelaic acid gel;hydroquinone cream
44 Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses Unknown status NCT01229319 Phase 4 Cryotherapy alone to Left arm plus cryotherapy + imiquimod to Right arm;Cryotherapy alone to Left arm plus cryotherapy + imiquimod to Right arm
45 Comparing Different Platelet Rich Plasma (PRP) Treatment Regimens for Management of Androgenic Alopecia Unknown status NCT02999737 Phase 4
46 Methylene Blue Intradermal Injection for Sentinel Lymph Node Biopsy for Breast Cancer Patients Unknown status NCT02982148 Phase 4
47 The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy Unknown status NCT02905916 Phase 4 PEG-rhG-CSF
48 Doxorubicin Hydrochloride Liposome Injection Combination With Cyclophosphamide vs Pirarubicin Combination With Cyclophosphamide in Patients With Locally Advanced Breast Cancer Unknown status NCT02903524 Phase 4 Doxorubicin Hydrochloride Liposome injection and cyclophosphamide;pirarubicin and cyclophosphamide
49 Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast Cancer Unknown status NCT02781259 Phase 4 Indocyanine green
50 Integrated Positron Emission Tomography Magnetic Resonance (PET/MR) of Breast Cancer Unknown status NCT02766530 Phase 4

Search NIH Clinical Center for Skin Conditions

Inferred drug relations via UMLS 74 / NDF-RT 52 :


Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Skin Conditions cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Skin Conditions:
BioDFactor, amniotic derived tissue for wound healing
Stemedyne-MSC, mesenchymal stem cells for cutaneous photoaging
Embryonic/Adult Cultured Cells Related to Skin Conditions:
Bone marrow-derived mesenchymal stem cells (Stemedyne�-MSC, itMSC) PMIDs: 23295150

Genetic Tests for Skin Conditions

Anatomical Context for Skin Conditions

MalaCards organs/tissues related to Skin Conditions:

42
Skin, Breast, Testes, Lymph Node, Bone, Brain, T Cells

Publications for Skin Conditions

Articles related to Skin Conditions:

(show top 50) (show all 463)
# Title Authors Year
1
A Comparison of Two Chronic Skin Conditions: Atopic Dermatitis and Psoriasis. ( 30859539 )
2019
2
Correlations between skin hydration parameters and corneocyte-derived parameters to characterize skin conditions. ( 29603859 )
2019
3
A qualitative examination of the experience of skin camouflage by people living with visible skin conditions. ( 30657172 )
2019
4
The development of a self-help intervention to build social confidence in people living with visible skin conditions or scars: a think-aloud study. ( 30675396 )
2019
5
Cohort Using a Ceramides Containing Cleanser and Cream With Salicylic Acid for Dry, Flaking, and Scaling Skin Conditions ( 30681802 )
2019
6
Effects of hot water extract of Curcuma longa on human epidermal keratinocytes in vitro and skin conditions in healthy participants: A randomized, double-blind, placebo-controlled trial. ( 30809971 )
2019
7
The clinical effect of glutathione on skin color and other related skin conditions: A systematic review. ( 30895708 )
2019
8
The role of diet in preventing photoaging and treating common skin conditions. ( 31039233 )
2019
9
Protean Neurologic Manifestations of Two Rare Dermatologic Disorders: Sweet Disease and Localized Craniofacial Scleroderma. ( 30747288 )
2019
10
An approach on the potential use of probiotics in the treatment of skin conditions: acne and atopic dermatitis. ( 29676446 )
2018
11
Compassion-focused self-help for skin conditions in individuals with insecure attachment: a pilot evaluation of acceptability and potential effectiveness. ( 28869774 )
2018
12
Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients. ( 29273489 )
2018
13
The role of adult attachment orientation and coping in psychological adjustment to living with skin conditions. ( 29274241 )
2018
14
A Randomized Controlled Trial Determining Variances in Ostomy Skin Conditions and the Economic Impact (ADVOCATE Trial). ( 29300287 )
2018
15
Improvement of skin conditions by ingestion of Aspergillus kawachii (Koji) extract containing 14-dehydroergosterol in a randomized, double-blind, controlled trial. ( 29563825 )
2018
16
Ultra-Low Dosage Regimen of Rituximab in Autoimmune Blistering Skin Conditions. ( 29720979 )
2018
17
Psychosocial adjustment to skin conditions resulting in visible difference (disfigurement): What do we know? Why don't we know more? How shall we move forward? ( 29872669 )
2018
18
Assessment and management of skin conditions in older people. ( 30063391 )
2018
19
Developing sensitivity to the psychological burden associated with skin conditions: a call for training. ( 30141548 )
2018
20
Could we be doing more to provide an evidence base for rare skin conditions? ( 30141565 )
2018
21
Effect of Torula Yeast (Candida utilis)-Derived Glucosylceramide on Skin Dryness and Other Skin Conditions in Winter. ( 30175789 )
2018
22
Long-Range Diagnosis of and Support for Skin Conditions in Field Settings. ( 30274480 )
2018
23
Disentangling the Complexity of a Hexa-Herbal Chinese Medicine Used for Inflammatory Skin Conditions-Predicting the Active Components by Combining LC-MS-Based Metabolite Profiles and in vitro Pharmacology. ( 30344490 )
2018
24
Effects of Composite Supplement Containing Collagen Peptide and Ornithine on Skin Conditions and Plasma IGF-1 Levels-A Randomized, Double-Blind, Placebo-Controlled Trial. ( 30513923 )
2018
25
Self-management of chronic skin conditions. ( 30521388 )
2018
26
Systematic mapping review about costs and economic evaluations of skin conditions and diseases in the aged. ( 27544020 )
2017
27
Dry skin conditions are related to the recovery rate of skin temperature after cold stress rather than to blood flow. ( 27917468 )
2017
28
Inflammatory Skin Conditions Associated With Radiotherapy. ( 28010872 )
2017
29
Nutritional Status and Habitual Dietary Intake Are Associated with Frail Skin Conditions in Community-Dwelling Older People. ( 28112767 )
2017
30
The cutaneous ecosystem: the roles of the skin microbiome in health and its association with inflammatory skin conditions in humans and animals. ( 28133874 )
2017
31
The Potential Psychological Impact of Skin Conditions. ( 28150109 )
2017
32
Common Skin Conditions in Children: Foreword. ( 28196315 )
2017
33
Common Skin Conditions in Children: Neonatal Skin Lesions. ( 28196316 )
2017
34
Common Skin Conditions in Children: Noninfectious Rashes. ( 28196317 )
2017
35
Common Skin Conditions in Children: Skin Infections. ( 28196318 )
2017
36
Common Skin Conditions in Children: Congenital Melanocytic Nevi and Infantile Hemangiomas. ( 28196319 )
2017
37
The impact of skin conditions on generic health-related quality of life. ( 28504391 )
2017
38
Dermoscopy, Confocal Microscopy and other Non-invasive Tools for the Diagnosis of Non-Melanoma Skin Cancers and Other Skin Conditions. ( 28676883 )
2017
39
Context for Practice: Clinical Challenges Related to Rare and Uncommon Skin Conditions. ( 28682852 )
2017
40
Effects of intake of Lactobacillus casei subsp. casei 327 on skin conditions: a randomized, double-blind, placebo-controlled, parallel-group study in women. ( 28748132 )
2017
41
Amelioration of atopic-like skin conditions in NC/Tnd mice by topical application with distilled Alpinia intermedia Gagnep extracts. ( 28815692 )
2017
42
CMS MDS 3.0 Section M Skin Conditions in Long-term Care: Pressure Ulcers, Skin Tears, and Moisture-Associated Skin Damage Data Update. ( 28817452 )
2017
43
CMS MDS 3.0 Section M Skin Conditions in Long-term Care: Pressure Ulcers, Skin Tears, and Moisture-Associated Skin Damage Data Update. ( 28817454 )
2017
44
Patient-centred health care for people with chronic skin conditions. ( 28833008 )
2017
45
Millimeter-wave emissivity as a metric for the non-contact diagnosis of human skin conditions. ( 28836682 )
2017
46
Application of three hygrometers under different skin conditions in dogs: dry, moist and haired skin. ( 28868812 )
2017
47
Associations between skin barrier characteristics, skin conditions and health of aged nursing home residents: a multi-center prevalence and correlational study. ( 29132305 )
2017
48
Topical pine tar: History, properties and use as a treatment for common skin conditions. ( 26790564 )
2017
49
The epidemiology of skin conditions in the aged: A systematic review. ( 27161662 )
2017
50
Obstructive sleep apnea and dermatologic disorders. ( 28511831 )
2017

Variations for Skin Conditions

Expression for Skin Conditions

Search GEO for disease gene expression data for Skin Conditions.

Pathways for Skin Conditions

GO Terms for Skin Conditions

Cellular components related to Skin Conditions according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.43 IFNK IGFL1 IGFL2 IGFL3 IL1A TNF
2 extracellular region GO:0005576 9.17 DCD IFNK IGFL1 IGFL2 IGFL3 IL1A

Biological processes related to Skin Conditions according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine-mediated signaling pathway GO:0019221 9.43 IFNK IL1A TNF
2 humoral immune response GO:0006959 9.32 IFNK TNF
3 negative regulation of extrinsic apoptotic signaling pathway in absence of ligand GO:2001240 9.16 IL1A TNF
4 positive regulation of cytokine secretion GO:0050715 8.96 IL1A TNF
5 positive regulation of protein localization to cell surface GO:2000010 8.62 CD247 TNF

Molecular functions related to Skin Conditions according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 8.8 IFNK IL1A TNF

Sources for Skin Conditions

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....